• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

综合疾病管理项目对改善心力衰竭患者临床结局的有效性:一项荟萃分析。

Effectiveness of comprehensive disease management programmes in improving clinical outcomes in heart failure patients. A meta-analysis.

作者信息

Roccaforte Rosa, Demers Catherine, Baldassarre Fulvia, Teo Koon K, Yusuf Salim

机构信息

Population Health Research Institute, McMaster University, and Hamilton Health Sciences, Ontario, Canada.

出版信息

Eur J Heart Fail. 2005 Dec;7(7):1133-44. doi: 10.1016/j.ejheart.2005.08.005. Epub 2005 Sep 29.

DOI:10.1016/j.ejheart.2005.08.005
PMID:16198629
Abstract

BACKGROUND

Disease management programmes (DMP) have been advocated to improve long term outcomes of heart failure (HF) patients.

AIMS

To summarise the evidence supporting DMP effectiveness in improving HF clinical outcomes.

METHODS

Eligible studies were located through a systematic literature search. Only randomised controlled trials (RCTs), enrolling HF patients, and allocating them to DMP or usual care (UC), were included. Information on study setting and design, participants' characteristics and interventions tested were collected. A study quality assessment was performed. Main clinical outcomes assessed were: all-cause mortality and (re)hospitalisations, HF-related (re)hospitalisations and mortality. Meta-analysis was performed according to both Yusuf-Peto method and random effects model.

RESULTS

Thirty-three RCTs were included. Mortality was significantly reduced by DMP compared to UC: OR = 0.80 (CI 0.69-0.93, p = 0.003). All-cause and HF-related hospitalisation rates were also significantly reduced: OR = 0.76 (CI 0.69-0.94, p < 0.00001) and OR = 0.58 (CI 0.50-0.67, p < 0.00001), respectively. Different DMP approaches appeared to be equally effective (sensitivity analyses).

CONCLUSION

DMP reduce mortality and hospitalisations in HF patients. Because various types of DMP appear to be similarly effective, the choice of a specific programme depends on local health services characteristics, patient population, and resources available.

摘要

背景

疾病管理项目(DMP)已被提倡用于改善心力衰竭(HF)患者的长期预后。

目的

总结支持DMP在改善HF临床结局方面有效性的证据。

方法

通过系统的文献检索找到符合条件的研究。仅纳入招募HF患者并将其分配至DMP或常规护理(UC)的随机对照试验(RCT)。收集有关研究背景和设计、参与者特征以及所测试干预措施的信息。进行研究质量评估。评估的主要临床结局包括:全因死亡率和(再)住院率、HF相关(再)住院率和死亡率。根据Yusuf-Peto方法和随机效应模型进行荟萃分析。

结果

纳入33项RCT。与UC相比,DMP显著降低了死亡率:OR = 0.80(CI 0.69 - 0.93,p = 0.003)。全因和HF相关住院率也显著降低:分别为OR = 0.76(CI 0.69 - 0.94,p < 0.00001)和OR = 0.58(CI 0.50 - 0.67,p < 0.00001)。不同的DMP方法似乎同样有效(敏感性分析)。

结论

DMP可降低HF患者的死亡率和住院率。由于各种类型的DMP似乎同样有效,特定项目的选择取决于当地卫生服务特点、患者群体和可用资源。

相似文献

1
Effectiveness of comprehensive disease management programmes in improving clinical outcomes in heart failure patients. A meta-analysis.综合疾病管理项目对改善心力衰竭患者临床结局的有效性:一项荟萃分析。
Eur J Heart Fail. 2005 Dec;7(7):1133-44. doi: 10.1016/j.ejheart.2005.08.005. Epub 2005 Sep 29.
2
Disease management programmes for older people with heart failure: crucial characteristics which improve post-discharge outcomes.针对老年心力衰竭患者的疾病管理项目:改善出院后结局的关键特征。
Eur Heart J. 2006 Mar;27(5):596-612. doi: 10.1093/eurheartj/ehi656. Epub 2005 Nov 18.
3
Two-year outcome of a prospective, controlled study of a disease management programme for elderly patients with heart failure.一项针对老年心力衰竭患者疾病管理项目的前瞻性对照研究的两年结果。
J Cardiovasc Med (Hagerstown). 2007 May;8(5):324-9. doi: 10.2459/JCM.0b013e32801164cb.
4
Heart failure management: optimal health care delivery programs.心力衰竭管理:优化医疗保健提供方案。
Annu Rev Nurs Res. 2000;18:91-126.
5
Usefulness of frailty profile for targeting older heart failure patients in disease management programs: a cost-effectiveness, pilot study.衰弱表型在疾病管理计划中针对老年心力衰竭患者的实用性:一项成本效益的试点研究。
J Cardiovasc Med (Hagerstown). 2010 Oct;11(10):739-47. doi: 10.2459/JCM.0b013e328339d981.
6
Heart failure disease management a sustainable energy source for the health care engine.心力衰竭疾病管理:医疗保健引擎的可持续能源
J Am Coll Cardiol. 2010 Jul 27;56(5):379-81. doi: 10.1016/j.jacc.2010.04.021.
7
Do patients with heart failure need a case manager?心力衰竭患者需要个案管理员吗?
J Cardiovasc Nurs. 2009 Mar-Apr;24(2):127-31. doi: 10.1097/JCN.0b013e318197a9c6.
8
Heart failure management program improves outcomes, saves millions at UCLA.心力衰竭管理项目改善了治疗效果,在加州大学洛杉矶分校节省了数百万美元。
Health Care Cost Reengineering Rep. 1997 Nov;2(11):166-70.
9
Improving the outcomes of heart failure care: putting technology second.改善心力衰竭护理的结果:将技术置于次要位置。
J Am Coll Cardiol. 2005 May 17;45(10):1665-6. doi: 10.1016/j.jacc.2005.02.036.
10
Multicenter randomized trial of a comprehensive hospital discharge and outpatient heart failure management program.一项关于综合医院出院及门诊心力衰竭管理项目的多中心随机试验。
Eur J Heart Fail. 2004 Aug;6(5):643-52. doi: 10.1016/j.ejheart.2003.11.023.

引用本文的文献

1
Efficacy of Nurse-Led and Multidisciplinary Self-Management Programmes for Heart Failure with Reduced Ejection Fraction: An Umbrella Systematic Review.护士主导及多学科自我管理方案对射血分数降低的心力衰竭患者的疗效:一项伞形系统评价
Biomedicines. 2025 Aug 11;13(8):1955. doi: 10.3390/biomedicines13081955.
2
Historical Gaps in the Integration of Patient-Centric Self-Management Components in HFrEF Interventions: An Umbrella Narrative Review.射血分数降低的心力衰竭(HFrEF)干预措施中以患者为中心的自我管理组件整合方面的历史差距:一项伞状叙述性综述
J Clin Med. 2025 Apr 19;14(8):2832. doi: 10.3390/jcm14082832.
3
Promoting Diversity in Cardiac Rehabilitation Programs at Community Hospitals.
促进社区医院心脏康复项目的多样性。
Circ Rep. 2025 Mar 15;7(4):219-222. doi: 10.1253/circrep.CR-25-0017. eCollection 2025 Apr 10.
4
Effect of long-term rehabilitation on takotsubo syndrome-induced severe intensive care unit-acquired weakness: a case report.长期康复治疗对Takotsubo综合征所致严重重症监护病房获得性肌无力的影响:一例报告
J Phys Ther Sci. 2024 Nov;36(11):750-755. doi: 10.1589/jpts.36.750. Epub 2024 Nov 1.
5
An Innovative Patient-Centred Approach to Heart Failure Management: The Best Care Heart Failure Integrated Disease-Management Program.一种创新的以患者为中心的心力衰竭管理方法:最佳护理心力衰竭综合疾病管理项目。
CJC Open. 2024 Apr 10;6(8):989-1000. doi: 10.1016/j.cjco.2024.03.015. eCollection 2024 Aug.
6
Expert Recommendations to Bridge Gaps in Heart Failure Patient Support in the Middle East and Africa Region.中东和非洲地区心力衰竭患者支持方面的差距弥补专家建议。
Anatol J Cardiol. 2024 Jan;28(1):2-18. doi: 10.14744/AnatolJCardiol.2023.3517.
7
Impact of the COVID-19 pandemic on implementation of novel guideline-directed medical therapies for heart failure in Germany: a nationwide retrospective analysis.新冠疫情对德国心力衰竭新型指南导向药物治疗实施情况的影响:一项全国性回顾性分析
Lancet Reg Health Eur. 2023 Nov 7;35:100778. doi: 10.1016/j.lanepe.2023.100778. eCollection 2023 Dec.
8
Efficacy of disease management program used among patients with chronic heart failure: protocol for a systematic review and network meta-analysis.疾病管理方案在慢性心力衰竭患者中的疗效:系统评价和网络荟萃分析方案。
Syst Rev. 2023 Feb 28;12(1):27. doi: 10.1186/s13643-023-02183-8.
9
The need for increased pragmatism in cardiovascular clinical trials.心血管临床试验需要增加务实性。
Nat Rev Cardiol. 2022 Nov;19(11):737-750. doi: 10.1038/s41569-022-00705-w. Epub 2022 May 17.
10
Primary care-based integrated disease management for heart failure: a study protocol for a cluster randomised controlled trial.基于初级保健的心力衰竭综合疾病管理:一项群组随机对照试验的研究方案。
BMJ Open. 2022 May 12;12(5):e058608. doi: 10.1136/bmjopen-2021-058608.